HQY Healthequity Inc

Price (delayed)

$73.63

Market cap

$6.3B

P/E Ratio

490.87

Dividend/share

N/A

EPS

$0.15

Enterprise value

$6.95B

HealthEquity and its subsidiaries administer HSAs and other consumer-directed benefits for its more than 12 million accounts in partnership with employers, benefits advisors, and health and retirement plan providers who ...

Highlights
HQY's net income has surged by 121% year-on-year
HQY's EPS has surged by 120% year-on-year

Key stats

What are the main financial stats of HQY
Market
Shares outstanding
85.63M
Market cap
$6.3B
Enterprise value
$6.95B
Valuations
Price to book (P/B)
3.23
Price to sales (P/S)
6.71
EV/EBIT
95.47
EV/EBITDA
30.07
EV/Sales
7.41
Earnings
Revenue
$937.91M
EBIT
$72.8M
EBITDA
$231.17M
Free cash flow
$170.74M
Per share
EPS
$0.15
Free cash flow per share
$2
Book value per share
$22.81
Revenue per share
$10.97
TBVPS
$6.27
Balance sheet
Total assets
$3.07B
Total liabilities
$1.12B
Debt
$935.98M
Equity
$1.95B
Working capital
$319.29M
Liquidity
Debt to equity
0.48
Current ratio
4.09
Quick ratio
3.71
Net debt/EBITDA
2.79
Margins
EBITDA margin
24.6%
Gross margin
59.7%
Net margin
1.4%
Operating margin
7.1%
Efficiency
Return on assets
0.4%
Return on equity
0.7%
Return on invested capital
6.6%
Return on capital employed
2.5%
Return on sales
7.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

HQY stock price

How has the Healthequity stock price performed over time
Intraday
-0.08%
1 week
3.78%
1 month
8.04%
1 year
4.2%
YTD
19.45%
QTD
16.61%

Financial performance

How have Healthequity's revenue and profit performed over time
Revenue
$937.91M
Gross profit
$559.86M
Operating income
$66.68M
Net income
$12.83M
Gross margin
59.7%
Net margin
1.4%
HQY's net income has surged by 121% year-on-year
The net margin has surged by 118% year-on-year
HQY's operating income has surged by 69% since the previous quarter
Healthequity's operating margin has soared by 61% from the previous quarter

Growth

What is Healthequity's growth rate over time

Valuation

What is Healthequity stock price valuation
P/E
490.87
P/B
3.23
P/S
6.71
EV/EBIT
95.47
EV/EBITDA
30.07
EV/Sales
7.41
HQY's EPS has surged by 120% year-on-year
The stock's P/B is 25% below its 5-year quarterly average of 4.3 but 11% above its last 4 quarters average of 2.9
The equity has grown by 4.5% YoY
The stock's price to sales (P/S) is 24% less than its 5-year quarterly average of 8.8 but 7% more than its last 4 quarters average of 6.3
HQY's revenue is up by 18% year-on-year and by 4.2% since the previous quarter

Efficiency

How efficient is Healthequity business performance
The ROE has soared by 121% YoY
The ROA has soared by 120% YoY
HQY's ROIC has soared by 74% QoQ
HQY's return on sales has surged by 63% since the previous quarter

Dividends

What is HQY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HQY.

Financial health

How did Healthequity financials performed over time
Healthequity's total assets is 175% higher than its total liabilities
HQY's quick ratio has surged by 74% year-on-year and by 2.8% since the previous quarter
Healthequity's current ratio has surged by 66% YoY and by 2.3% QoQ
The debt is 52% smaller than the equity
The debt to equity has declined by 11% year-on-year and by 2% since the previous quarter
The debt has declined by 7% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.